Xeris Biopharma Holdings Raises FY2025 Sales Guidance from $280.000M-$290.000M to $285.000M-$290.000M vs $286.467M Est
Benzinga Newsdesk 12 months ago
NewsGuidance
Xeris Biopharma Holdings (NASDAQ:XERS) raises FY2025 sales outlook from $280.000 million-$290.000 million to $285.000 million-$290.000 million vs $286.467 million estimate.
Xeris Biopharma Holdings (NASDAQ:XERS) raises FY2025 sales outlook from $280.000 million-$290.000 million to $285.000 million-$290.000 million vs $286.467 million estimate.